Use of polymyxins and tetracycline antibiotics in the prevention and treatment of ocular diseases in dogs caused by bacterial infections
The combined use of polymyxins and tetracycline antibiotics has solved the problems of narrow antibacterial spectrum and drug resistance in the treatment of bacterial eye infections in dogs, providing a broad-spectrum treatment plan with significant synergistic effects and enhancing antibacterial efficacy against both Gram-negative and Gram-positive bacteria.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JINHE BIOTECHNOLOGY CO LTD
- Filing Date
- 2026-05-14
- Publication Date
- 2026-07-17
AI Technical Summary
In the current technology, the treatment of bacterial eye infections in dogs mainly relies on single antibacterial drugs, which have problems such as limited antibacterial spectrum, easy development of drug resistance and poor treatment effect. There is a lack of broad-spectrum drug combinations with significant synergistic effects.
The combined use of polymyxins and tetracycline antibiotics, through different proportions of drug combinations, targets Gram-negative and Gram-positive bacterial infections, and is formulated into ophthalmic dosage forms such as eye drops and ointments, which are used in combination to enhance the antibacterial effect.
It significantly enhances the antibacterial spectrum against bacterial eye infections in dogs, reduces the emergence of drug-resistant strains, and provides a more effective treatment option.
Smart Images
Figure CN122398992A_ABST